ArticleJournal of human genetics2026
A novel homozygous splicing variant in FRA10AC1: further delineation of the phenotype.
Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Biallelic variants in FRA10AC1, encoding a component of the spliceosomal C complex that is crucial for functional mRNA processing, have been recently associated with a neurodevelopmental disorder characterized by developmental delay, variable dysmorphic facies, growth retardation, and corpus callosum abnormalities. Skeletal and congenital heart defects were observed in some patients. To date, only 10 patients from 6 unrelated families with FRA10AC1 variants have been reported in the literature. Herein, we describe a new patient harboring a loss-of-function variant in FRA10AC1. Our patient presented with global developmental delay, hypotonia, dysmorphic facies, hyperactivity, and severe intellectual disability. He had no seizures. Unusual findings noted in the patient were fused kidneys and bilateral cone dystrophy. Brain MRI showed a hypoplastic corpus callosum, delayed myelination, and a small cyst in the caudate nucleus. Exome sequencing revealed a novel homozygous variant in the donor splice site of exon 7 of the FRA10AC1 (c.465+1G>A) as the likely cause of the patient's phenotype. Thorough investigations of the exome data did not reveal any additional potential pathogenic variants to justify the patient's renal and ocular phenotypes. The identified c.465+1G>A was confirmed by studying the patient's mRNA to result in exon skipping and early protein truncation, p.(Trp127CysfsTer8). Our study increases the number of patients and variants associated with FRA10AC1-related disorder and contributes to increasing our understanding of FRA10AC1 role in neurodevelopmental disorders. In addition, it reinforces kidney and ocular anomalies as part of this multisystem disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.